Đang chuẩn bị liên kết để tải về tài liệu:
Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: A case report

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Primary hepatic angiosarcoma (PHA) is a rare and aggressive solid tumor, with high rates of local recurrence and distant metastasis, and poor prognosis. There are no established treatment guidelines for PHA. | Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma A case report

TÀI LIỆU LIÊN QUAN

Rare outbreak of fowl cholera in waterfowls in Dal lake area of Kashmir, with isolation, antibiogram and successful treatment - A report

Successful treatment of a reinfected liver graft because of receipt of a HCV-positive kidney

Successful horn amputation for the treatment of horn cancer in an 18 year old humped bullock

Ebook Case studies in child, adolescent , and family treatment (2/E): Part 2

Lung squamous cell carcinoma with solitary ocular metastasis and its successful treatment with thoracic surgery and chemotherapy: An interesting and rare case report

Báo cáo y học: " Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report"

Báo cáo y học: " Successful treatment of severe sinusoidal obstruction syndrome despite multiple organ failure with defibrotide after allogeneic stem cell transplantation: a case report"

Báo cáo y học: " Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report"

Báo cáo y học: " Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizuma"

Báo cáo y học: " T cell activity in successful treatment of chronic urticaria with omalizumab"
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.